LakeShore Biopharma Co Net Income

As of the most recent data (March 2024), YS shows a net income of $-430M. That is below the sector sector average of $89M. Scroll down for historical charts and peer comparison views.

The its sector sector average net income is about $89M. LakeShore Biopharma Co is at $-430M, which is lower that average. That is roughly 587.7% below the sector mean. Use the comparison chart on this page to see how YS stacks up against individual peers as well.

Tracking YS's net income over time shows whether LakeShore Biopharma Co is scaling, shrinking, or reshaping that part of the business. The current reading is $-430M Multi-quarter patterns matter more than any single print, which is why this page emphasizes history and peer comparison charts.

Besides this net income page, Stockcircle has LakeShore Biopharma Co's full stock overview, other financial metrics, insider and congress trade tabs, and tools to follow the stock. Together they help you connect net income (currently $-430M) with ownership activity and broader fundamentals.